Table 2.

Characteristics of interventions and controls.

Author	Glibenclamide dose	Route of administration	Duration of treatment	Type of placebo
da Costa et al. (8)	5 mg	Oral, NGT	21 days	Starch
Feng et al. (7)	15 mg	Oral, NGT	10 days	Vitamin B1
Lin et al. (4)	3.75 mg	oral	7 days	None
Sheth et al. (12)	IV 0.13 mg bolus during first 2 min, followed by IV infusion at a rate of 0.16 mg/h for 6 h, followed by 0.11 mg/h for 66 h	IV	3 days	NR
Windlin et al. (11)	5 mg	Oral, NGT	21 days	Placebo (not otherwise defined)
Zhao et al. (9)	1.25 mg, 3 times/day	oral	7 days	Standard care (not otherwise defined)